Genomic Valley Biotech Reports Q1 FY26 Results, Announces Key Appointments
Genomic Valley Biotech Limited (GVBL) released Q1 FY26 results, showing a 31.56% decrease in revenue to Rs. 6,16,000 and an 80.67% drop in net profit to Rs. 2,46,531 compared to Q1 FY25. The company appointed M/s. SBR & Co. LLP as Secretarial Auditors for 2025-2030, Mr. Navjyoti Kumar Jha as Internal Auditor for FY 2025-26, and re-appointed Mr. Yogesh Agrawal as Chairman & Managing Director for five years from September 7, 2025.